| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |